Ashraf Kamour

Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study

Simon L. Hill, Javad Najafi, Michael Dunn et al. · Clinical Toxicology · 2016 · 53 citations

Increasing frequency of severe clinical toxicity after use of 2,4-dinitrophenol in the UK: a report from the National Poisons Information Service

Ashraf Kamour, Nathan George, David Gwynnette et al. · Emergency Medicine Journal · 2014 · 47 citations

Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates

Nawal Al Kaabi, Abderrahim Oulhaj, Subhashini Ganesan et al. · Nature Communications · 2022 · 35 citations · Full text

Central nervous system toxicity of mefenamic acid overdose compared with other NSAIDs: an analysis of cases reported to the United Kingdom National Poisons Information Service

Ashraf Kamour, Siobhan Crichton, G. D. Cooper et al. · British Journal of Clinical Pharmacology · 2016 · 30 citations · Full text

Patterns of presentation and clinical toxicity after reported use of alpha methyltryptamine in the United Kingdom. A report from the UK National Poisons Information Service

Ashraf Kamour, David A. James, Robert Spears et al. · Clinical Toxicology · 2014 · 23 citations